Kyleena 19.5 MG systems
Ended Awarded
- Contract number
- SPE2DB26FNMNJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,718
Award facts
- Contract value 100% obligated
- $3,718.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,718.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Kyleena 19.5 mg contraceptive systems. The contract, effective November 4, 2025, with an ultimate completion date of November 26, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support Department of Defense pharmaceutical supply needs globally.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier for military healthcare facilities under the PPV-G GEN V contract, which was awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036. The IDC authorizes the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. As one of multiple regional prime vendor contractors under this initiative, DMS Pharmaceutical Group has demonstrated substantial contracting capacity and performance across diverse pharmaceutical categories supporting the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FNMNJ?
SPE2DB26FNMNJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FNMNJ worth?
The government has obligated $3,718 on SPE2DB26FNMNJ.
Is contract SPE2DB26FNMNJ an order under another contract?
Yes. SPE2DB26FNMNJ is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB26FNMNJ competed?
The extent of competition for SPE2DB26FNMNJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award